Faculty of Pharmaceutical Sciences, Hokkaido University, Kita 12 Nishi 6, Kita-ku, Sapporo 060-0812, Japan.
Faculty of Pharmaceutical Sciences, Hokkaido University, Kita 12 Nishi 6, Kita-ku, Sapporo 060-0812, Japan.
Acta Biomater. 2020 Jan 15;102:341-350. doi: 10.1016/j.actbio.2019.11.022. Epub 2019 Nov 13.
Despite the fact that small-sized lipid nanoparticles (LNPs) are important for improved tissue penetration and efficient drug delivery, their poor stability and intracellular trafficking significantly hinders their use as potent small-sized LNPs. It has been reported that both the diffusion of lipid components from LNPs and the adsorption of proteins on the surface of LNPs are responsible for their decreased potency. To overcome this issue, we focused on the chemical structure of hydrophobic scaffolds of pH-sensitive cationic lipids with various lengths and shapes. LNPs composed of a pH-sensitive cationic lipid with long, linear scaffolds induced gene silencing in a dose-dependent manner, while LNPs with a classical scaffold length (C18) failed. Replacing the helper lipid from cholesterol to egg sphingomyelin (ESM) resulted in the formation of smaller LNPs with a diameter of ~22 nm and enhanced gene silencing activity. Most of the ESMs were located in the outer layer and functioned to stabilize the LNPs. Long, linear scaffolds contributed to immiscibility with phosphocholine-containing lipids including ESM. This contribution was dependent on the scaffold length of pH-sensitive cationic lipids. Although phosphocholine-containing lipids usually inhibit membrane fusion-mediated endosomal escape, long, linear scaffolds contributed to avoiding the inhibitory effect and to enhance the potency of the LNPs. These findings provide useful information needed for the rational design of pH-sensitive cationic lipid structures and the selection of appropriate helper lipids and will facilitate the development of highly potent small-sized LNPs. STATEMENT OF SIGNIFICANCE: Despite the fact that small-sized lipid nanoparticles (LNPs) are important for improved tissue penetration and efficient drug delivery, the size reduction-associated decrease in the stability and intracellular trafficking significantly hinders the development of potent small-sized LNPs. Our limited understanding of the mechanism underlying the reduced potency has also hindered the development of more potent small-sized LNPs. The findings of the present study indicate that long and linear hydrophobic scaffolds of pH-sensitive cationic lipids could overcome the loss of efficiency for nucleic acid delivery. In addition, the long hydrophobic scaffolds led to immiscibility with neutral phospholipids, resulting in efficient endosomal escape. These findings provide useful information needed for the rational design of pH-sensitive cationic lipid structures and will facilitate the development of highly potent small-sized LNPs.
尽管小尺寸脂质纳米颗粒 (LNPs) 对于改善组织穿透和提高药物递送效率非常重要,但它们的稳定性差和细胞内转运能力差严重阻碍了它们作为有效小尺寸 LNPs 的应用。据报道,LNPs 中的脂质成分的扩散以及 LNPs 表面上蛋白质的吸附都导致了它们效力的降低。为了解决这个问题,我们专注于具有各种长度和形状的 pH 敏感阳离子脂质的疏水性支架的化学结构。由具有长线性支架的 pH 敏感阳离子脂质组成的 LNPs 以剂量依赖的方式诱导基因沉默,而具有经典支架长度 (C18) 的 LNPs 则没有。用蛋黄鞘磷脂 (ESM) 代替胆固醇作为辅助脂质,导致形成直径约为 22nm 的更小 LNPs,并增强了基因沉默活性。大多数 ESM 位于外层,起到稳定 LNPs 的作用。长线性支架有助于与含有磷酰胆碱的脂质(包括 ESM)不混溶。这种贡献取决于 pH 敏感阳离子脂质的支架长度。尽管含有磷酰胆碱的脂质通常会抑制膜融合介导的内体逃逸,但长线性支架有助于避免抑制作用并增强 LNPs 的效力。这些发现为合理设计 pH 敏感阳离子脂质结构以及选择合适的辅助脂质提供了有用的信息,并将有助于开发高效的小尺寸 LNPs。
尽管小尺寸脂质纳米颗粒 (LNPs) 对于改善组织穿透和提高药物递送效率非常重要,但尺寸减小相关的稳定性和细胞内转运能力的降低严重阻碍了高效小尺寸 LNPs 的发展。我们对降低效力的机制的有限了解也阻碍了更高效小尺寸 LNPs 的发展。本研究的结果表明,pH 敏感阳离子脂质的长而线性疏水性支架可以克服核酸递送效率的降低。此外,长疏水性支架与中性磷脂不相容,导致有效的内体逃逸。这些发现为合理设计 pH 敏感阳离子脂质结构提供了有用的信息,并将有助于开发高效的小尺寸 LNPs。